Maharashtra’ Food and Drug Administration has ordered an FIR against eCommerce giant Snapdeal founders Kunal Bahl and other directors for allegedly selling prescription based drugs on the website. The FDA had asked the company to furnish documents pertaining to the distribution and sale
Recent Posts
- India’s BRICS Chairship Delivers Consensus Amid Fractures: Practical Gains, Measured Diplomacy, and Limits of Alignment
- The 3-Paise Settlement: How India’s Financial Architecture Capitulated to Subhash Chandra’s ₹22,000-Crore Default
- Top 10 Indian IT Giants Raise the Bar on Employee Rewards
- The Sovereign Architects of India’s Digital Century: Top 50 Women IT Leaders
- PoK Gamble: Rhetoric Meets Realpolitik Along the Line of Control










